ERBB2 and neoplasm: In contrast, no significant associations were observed between the expression of the remaining lncRNAs and molecular subtype, receptor status (ER, PR, HER2), or tumor grade, indicating that their dysregulation may reflect general tumor progression rather than subtype-specific mechanisms.